drugset / Trial / NCT04142970

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

NCT04142970

Non-randomizedSequentialOpen-labelOther

Summary

A Clinical Study Comparatively Evaluating the Pharmacokinetics, Pharmacodynamics and Safety of Intravenous Administration of HSK3486 Injectable Emulsion in Patients with Chronic Renal Impairment and Subjects with Normal Renal Functions

Timeline

Start
2020-01-05
Primary completion
2020-08-04
Completion
2020-08-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cipepofol Small molecule 0.4 mg/kg Intravenous